North East Medical College Blog Blog Obstetrics & Gynecology Modern Management of Placenta Praevia and Low-Lying Placenta: An Evidence-Based Clinical Guide
Obstetrics & Gynecology

Modern Management of Placenta Praevia and Low-Lying Placenta: An Evidence-Based Clinical Guide

Clinical Scenario

A 32-year-old woman (G2P1) with a history of a previous caesarean birth presents to the clinic at 32 weeks of gestation for a follow-up ultrasound. Her mid-trimester scan had indicated an abnormally positioned placenta. She is currently asymptomatic but requires a definitive care map and delivery plan.

The 2026 Paradigm Shift: Simplified Classification

Accurate diagnosis dictates precise management. The clinical nomenclature has transitioned away from confusing legacy terms like “marginal” or “partial” placenta previa. Current protocols mandate a clear, distance-based binary definition via ultrasound imaging after 16 weeks of gestation:

  • Placenta Praevia: The placenta covers the internal os of the uterine cervix, either partially or completely.
  • Low-Lying Placenta: The leading edge of the placenta is less than 20 mm from the internal os, but does not cover it.

Placenta Praevia: The placenta covers the internal os of the uterine cervix, either partially or completely. Low-Lying Placenta: The leading edge of the placenta is less than 20 mm from the internal os, but does not cover it.

 

Key Clinical Questions & Evidence-Based Answers

Question 1: How should initial screening and subsequent diagnostic follow-up be structured?

  • The routine fetal anomaly screening (FAS) ultrasound examination at 18+0 to 20+6 weeks of gestation must systematically include an assessment of placental location.
  • Asymptomatic individuals with an initially identified low-lying placenta or placenta praevia should be offered a follow-up ultrasound examination, including a transvaginal scan (TVS) at 32 weeks of gestation, performed by an experienced operator.
  • TVS provides superior diagnostic accuracy compared to transabdominal ultrasound (TAS) and is completely safe to perform, even in cases presenting with mid-trimester or third-trimester bleeding.

Question 2: What is the standard of care for outpatients versus symptomatic inpatients?

  • Asymptomatic patients can be safely cared for as outpatients, provided they have clear safety measures in place, such as immediate access to transport and adequate support at home.
  • Symptomatic patients experiencing pain or antepartum bleeding require tailored antenatal care and hospitalisation based strictly on individual clinical factors and social circumstances.
  • For acute symptomatic presentations, tocolysis may be considered for a strict 48-hour window solely to facilitate the administration of antenatal corticosteroids, whereas cervical cerclage is explicitly not recommended.
  • Antenatal corticosteroids must be offered between 24+0 and 34+6 weeks of gestation (and magnesium sulphate up to 30+0 weeks) if imminent preterm birth is anticipated.

Question 3: Is a trial of labour permissible for a low-lying placenta?

  • A trial of labour should be discussed as a viable option if a third-trimester asymptomatic low-lying placenta demonstrates a placental edge-to-internal os distance between 11 mm and 20 mm after 36 weeks of gestation.
  • Patients choosing a trial of labour within this 11–20 mm window achieve a successful vaginal birth in more than 80% of cases, without experiencing a statistically significant increase in maternal or neonatal morbidity.

Question 4: What are the critical surgical standards for a planned delivery?

  • For uncomplicated presentations, the timing of a planned birth should be tailored to antenatal symptoms but scheduled no later than 37+6 weeks of gestation.
  • Delivery must take place in a maternity unit equipped with on-site blood transfusion services and immediate critical care access due to the inherently elevated risks of intraoperative haemorrhage, postpartum haemorrhage (PPH), and emergency hysterectomy.
  • A senior obstetrician and a senior anaesthetist must be physically present within the operating theatre suite during a planned caesarean birth.
  • Intraoperative cell salvage is highly beneficial and safe, serving as a critical modality to minimize donor blood requirements, particularly for patients who decline blood products for personal or religious reasons.
  • If standard first-line pharmacological agents (uterotonics and tranexamic acid) fail to control bleeding from the lower uterine segment, intrauterine balloon tamponade must be initiated immediately, and uterine compression sutures should be actively considered.

Conclusion

Optimal management of placenta praevia and low-lying placenta demands rigorous ultrasound surveillance and a meticulously planned delivery. Adhering to the updated distance-based classification ensures care is tailored directly to the patient’s specific anatomical presentation and symptom profile. By maintaining strict surgical standards and executing multidisciplinary coordination at the time of delivery, clinicians can effectively navigate the inherent complexities of placental abnormalities, maximizing safety and clinical outcomes for both the patient and the neonate.

References

Jauniaux E, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, et al. Placenta praevia and placenta accreta: diagnosis and management: Green-top guideline no. 27a. BJOG. 2019;126(1):e1-e48.

Leave a Reply

Your email address will not be published. Required fields are marked *

Exit mobile version